# Kolmar Korea Co., Ltd. - Gwanjeong Factory – FDA Inspection, Feb 16, 2024

Source: https://www.keypedia.com/records/fda_inspections/kolmar-korea-co-ltd-gwanjeong-factory/edc9193f-46a0-4074-938e-5d7c77446b1c
Source feed: FDA_Inspections

> FDA inspection 1230224 of Kolmar Korea Co., Ltd. - Gwanjeong Factory, February 16, 2024. Classification: Voluntary Action Indicated (VAI). 6 citations under 21 CFR part 211. 2 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1230224
- Company Name: Kolmar Korea Co., Ltd. - Gwanjeong Factory
- Inspection Date: 2024-02-16
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 6

## Related Documents

- [FDA Inspection 1173870 - 2022-07-07](https://www.keypedia.com/records/fda_inspections/kolmar-korea-co-ltd-gwanjeong-factory/c4989fec-cefe-4833-ad60-b3319b3eb902)
- FDA Inspection 1031995 - 2017-09-15

## Related Officers

- [Saleem A. Akhtar](https://www.keypedia.com/people/saleem-a-akhtar/1ea49212-bea5-4d43-bd0a-cdede4d3b1cf)

Company: https://www.keypedia.com/companies/kolmar-korea-co-ltd-gwanjeong-factory/392855b3-652a-43a6-abb2-d78b2b634c5e

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c